Skip to main content

Measuring Interferon Alpha and Other Cytokines in SLE

  • Protocol
  • First Online:
Systemic Lupus Erythematosus

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1134))

Abstract

The progression of disease in patients with systemic lupus erythematosus (SLE) is affected by production, accumulation, and actions of cytokines. Type I interferon (IFN), specifically IFN-α, is recognized as a central mediator of disease pathogenesis in SLE. We describe a functional assay to measure type I IFN activity in SLE plasma and have also measured the response of peripheral blood cells to that cytokine family. This method can be scaled to assess IFN functional activity, as well as activity and cellular response to other cytokines, in relation to cellular and serologic parameters relevant to SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Becker-Merok A, Østli-Eilersten G, Lester S et al (2013) Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Lupus 22:155–163

    Article  CAS  PubMed  Google Scholar 

  2. Crow MK, Wohlgemuth J (2003) Microarray analysis of gene expression in lupus. Arthritis Res Ther 5:279–287

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Bennett L, Palucka a K, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711–723

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Nzeusseu Toukap A, Galant C, Theate I et al (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 56:1579–1588

    Article  CAS  PubMed  Google Scholar 

  5. Crow MK (2010) Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 36:173–186

    Article  PubMed Central  PubMed  Google Scholar 

  6. Lövgren T, Eloranta M-L, Båve U et al (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861–1872

    Article  PubMed  Google Scholar 

  7. Crow MK (2008) Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 358:956–961

    Article  CAS  PubMed  Google Scholar 

  8. Wang C, Sandling JK, Hagberg N et al (2013) Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann Rheum Dis 72:96–103

    Article  CAS  PubMed  Google Scholar 

  9. Connolly JJ, Hakonarson H (2012) Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed Biotechnol 2012:1–17

    Article  Google Scholar 

  10. Mikita N, Ikeda T, Ishiguro M et al (2011) Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol 38: 839–849

    CAS  PubMed  Google Scholar 

  11. Poole BD, Niewold TB, Tsokos GC (2012) Cytokines in systemic lupus erythematosus 2011. J Biomed Biotechnol 2012:427824

    Article  PubMed Central  PubMed  Google Scholar 

  12. Su D-L, Lu Z-M, Shen M-N et al (2012) Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012:347141

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611–622

    Article  CAS  PubMed  Google Scholar 

  14. Overbergh L, Giulietti A, Valckx D et al (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33–43

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Boeuf P, Vigan-Womas I, Jublot D et al (2005) CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6:5

    Article  PubMed Central  PubMed  Google Scholar 

  16. Brazma A, Hingamp P, Quackenbush J (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29(4):365–371

    Article  CAS  PubMed  Google Scholar 

  17. Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80

    Article  PubMed Central  PubMed  Google Scholar 

  18. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57

    Article  CAS  Google Scholar 

  19. Samarajiwa SA, Forster S, Auchettl K et al (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37:D852–D857

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Seo Y-J, Kim G-H, Kwak H-J et al (2009) Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type I interferons. Pharmacology 84:135–144

    Article  CAS  PubMed  Google Scholar 

  21. Bürgi M, Prieto C, Etcheverrigaray M et al (2012) WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β. J Immunol Methods 381:70–74

    Article  Google Scholar 

  22. Hua J, Kirou K, Lee C et al (2006) Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 54:1906–1916

    Article  CAS  PubMed  Google Scholar 

  23. Yousefi S, Escobar MR, Gouldin CW (1985) A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am J Clin Pathol 83:735–740

    CAS  PubMed  Google Scholar 

  24. Hayflick L (1961) The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res 23:14–20

    Article  CAS  PubMed  Google Scholar 

  25. Nelson-Rees WA, Flandermeyer RR (1976) HeLa cultures defined. Science (New York, NY) 191:96–98

    Article  CAS  Google Scholar 

  26. Chen TR (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet 48:19–24

    Article  CAS  PubMed  Google Scholar 

  27. Nalbandian A, Crispín JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157:209–215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Novick D, Elbirt D, Miller G et al (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34:121–126

    Article  CAS  PubMed  Google Scholar 

  29. Okamoto H, Katsumata Y, Nishimura K et al (2004) Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 50:3731–3732

    Article  CAS  PubMed  Google Scholar 

  30. Vega L, Barbado J, Almansa R et al (2010) Prolonged standard treatment for systemic lupus erythematosus fails to normalize the secretion of innate immunity-related chemokines. Eur Cytokine Netw 21:71–76

    CAS  PubMed  Google Scholar 

  31. López P, Gómez J, Prado C et al (2008) Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35:1559–1566

    PubMed  Google Scholar 

  32. Park YB, Lee SK, Kim DS et al (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheum 16:283–288

    CAS  Google Scholar 

  33. George-Chandy A, Trysberg E, Eriksson K (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 10:R97

    Article  PubMed Central  PubMed  Google Scholar 

  34. Sarra M, Monteleone G (2010) Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J Biomed Biotechnol 2010:294582

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, New York

About this protocol

Cite this protocol

Olferiev, M., Lliguicota, M., Kirou, K.A., Crow, M.K. (2014). Measuring Interferon Alpha and Other Cytokines in SLE. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0326-9_10

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-0325-2

  • Online ISBN: 978-1-4939-0326-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics